The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Systemic Delivery of Recombinant Proteins by Genetically Modified Myoblasts
Abstract
The ability to stably deliver recombinant proteins to the systemic circulation would facilitate the treatment of a variety of acquired and inherited diseases. To explore the feasibility of the use of genetically engineered myoblasts as a recombinant protein delivery system, stable transfectants of the murine C2C12 myoblast cell line were produced that synthesize and secrete high levels of human growth hormone (hGH) in vitro. Mice injected with hGH-transfected myoblasts had significant levels of hGH in both muscle and serum that were stable for at least 3 weeks after injection. Histological examination of muscles injected with β-galactosidase-expressing C2C12 myoblasts demonstrated that many of the injected cells had fused to form multinucleated myotubes. Thus, genetically engineered myoblasts can be used for the stable delivery of recombinant proteins into the circulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle
YAFFE, D., & SAXEL, O. (1977) · Nature · doi:10.1038/270725a0 · Cited by 2,123
Miller, D. G., Adam, M. A., & Miller, A. D. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.8.4239 · Cited by 893
Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts
Partridge, T. A., Morgan, J. E., Coulton, G. R., Hoffman, E. P., & Kunkel, L. M. (1989) · Nature · doi:10.1038/337176a0 · Cited by 878
Lineage analysis in the vertebrate nervous system by retrovirus-mediated gene transfer.
Price, J., Turner, D., & Cepko, C. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.1.156 · Cited by 873
Plasticity of the Differentiated State
Blau, H. M., Pavlath, G. K., Hardeman, E. C., Chiu, C.-P., Silberstein, L., Webster, S. G., Miller, S. C., & Webster, C. (1985) · Science · doi:10.1126/science.2414846 · Cited by 837
Site-Specific Gene Expression in Vivo by Direct Gene Transfer into the Arterial Wall
Nabel, E. G., Plautz, G., & Nabel, G. J. (1990) · Science · doi:10.1126/science.2119055 · Cited by 569
Isolation and characterization of human muscle cells.
Blau, H. M., & Webster, C. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.9.5623 · Cited by 399
Ponder, K. P., Gupta, S., Leland, F., Darlington, G., Finegold, M., DeMayo, J., Ledley, F. D., Chowdhury, J. R., & Woo, S. L. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.4.1217 · Cited by 369
Dzierzak, E. A., Papayannopoulou, T., & Mulligan, R. C. (1988) · Nature · doi:10.1038/331035a0 · Cited by 338
Long-term in vivo expression of retrovirus-mediated gene transfer in mouse fibroblast implants.
Scharfmann, R., Axelrod, J. H., & Verma, I. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.11.4626 · Cited by 280
Cited by
Biomedical applications of collagen
Lee, C. H., Singla, A., & Lee, Y. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00691-3 · Cited by 1,945
The Basic Science of Gene Therapy
Mulligan, R. C. (1993) · Science · doi:10.1126/science.8493530 · Cited by 1,741
Rando, T. A., & Blau, H. M. (1994) · The Journal of cell biology · doi:10.1083/jcb.125.6.1275 · Cited by 936
Human gene therapy comes of age
Miller, A. D. (1992) · Nature · doi:10.1038/357455a0 · Cited by 908
VEGF Gene Delivery to Myocardium: Deleterious Effects of Unregulated Expression
Lee, R. J., Springer, M. L., Blanco-Bose, W. E., Shaw, R., Ursell, P. C., & Blau, H. M. (2000) · Circulation · doi:10.1161/01.cir.102.8.898 · Cited by 697
Recombinant adeno-associated virus for muscle directed gene therapy
Fisher, K. J., Jooss, K., Alston, J., Yang, Y., Haecker, S. E., High, K., Pathak, R., Raper, S. E., & Wilson, J. M. (1997) · Nature Medicine · doi:10.1038/nm0397-306 · Cited by 654
Kessler, P. D., Podsakoff, G. M., Chen, X., McQuiston, S. A., Colosi, P. C., Matelis, L. A., Kurtzman, G. J., & Byrne, B. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.14082 · Cited by 614
Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors
Kafri, T., Blömer, U., Peterson, D. A., Gage, F. H., & Verma, I. M. (1997) · Nature Genetics · doi:10.1038/ng1197-314 · Cited by 605
LIEBERMAN, J. R., DALUISKI, A., STEVENSON, S., JOLLA, L., WU, L., McALLISTER, P., LEE, Y. P., KABO, J. M., FINERMAN, G. A. M., BERK, A. J., et al. (1999) · The Journal of Bone & Joint Surgery · doi:10.2106/00004623-199907000-00002 · Cited by 527
Beauchamp, J. R., Morgan, J. E., Pagel, C. N., & Partridge, T. A. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.144.6.1113 · Cited by 514
Prevention of Islet Allograft Rejection with Engineered Myoblasts Expressing FasL in Mice
Lau, H. T., Yu, M., Fontana, A., & Stoeckert, C. J. (1996) · Science · doi:10.1126/science.273.5271.109 · Cited by 445
Gussoni, E., Pavlath, G. K., Lanctot, A. M., Sharma, K. R., Miller, R. G., Steinman, L., & Blau, H. M. (1992) · Nature · doi:10.1038/356435a0 · Cited by 434
Davis, H. L., Whalen, R. G., & Demeneix, B. A. (1993) · Human Gene Therapy · doi:10.1089/hum.1993.4.2-151 · Cited by 371
Springer, M. L., Chen, A. S., Kraft, P. E., Bednarski, M., & Blau, H. M. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80154-9 · Cited by 363
Prevascularization of porous biodegradable polymers
Mikos, A. G., Sarakinos, G., Lyman, M. D., Ingber, D. E., Vacanti, J. P., & Langer, R. (1993) · Biotechnology and Bioengineering · doi:10.1002/bit.260420606 · Cited by 350
The fate of individual myoblasts after transplantation into muscles of DMD patients
Gussoni, E., Blau, H. M., & Kunkel, L. M. (1997) · Nature Medicine · doi:10.1038/nm0997-970 · Cited by 330
Plasmid DNA Is Superior to Viral Vectors for Direct Gene Transfer into Adult Mouse Skeletal Muscle
Davis, H. L., Demeneix, B. A., Quantin, B., Coulombe, J., & Whalen, R. G. (1993) · Human Gene Therapy · doi:10.1089/hum.1993.4.6-733 · Cited by 307
Lieberman, J. R., Le, L. Q., Wu, L., Finerman, G. A. M., Berk, A., Witte, O. N., & Stevenson, S. (1998) · Journal of Orthopaedic Research · doi:10.1002/jor.1100160309 · Cited by 306
Skeletal muscle tissue engineering
Bach, A. D., Beier, J. P., Stern‐Staeter, J., & Horch, R. E. (2004) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2004.tb00466.x · Cited by 303
Dai, Y., Roman, M., Naviaux, R. K., & Verma, I. M. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.10892 · Cited by 302
Fu, T.-M., Ulmer, J. B., Caulfield, M. J., Deck, R. R., Friedman, A., Wang, S., Liu, X., Donnelly, J. J., Liu, M. A., & Wigzell, H. (1997) · Molecular Medicine · doi:10.1007/bf03401683 · Cited by 296
Differentiation and long-term survival of C2C12 myoblast grafts in heart.
Koh, G. Y., Klug, M. G., Soonpaa, M. H., & Field, L. J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116734 · Cited by 285
Wu, J. C., Sundaresan, G., Iyer, M., & Gambhir, S. S. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0460 · Cited by 273
A brief history of gene therapy
Friedmann, T. (1992) · Nature Genetics · doi:10.1038/ng1092-93 · Cited by 273
Rapid death of injected myoblasts in myoblast transfer therapy
Fan, Y., Maley, M., Beilharz, M., & Grounds, M. (1996) · Muscle & Nerve · doi:10.1002/(sici)1097-4598(199607)19:7<853::aid-mus7>3.0.co;2-8 · Cited by 269
ULMER, J. B., DECK, R. R., DEWITT, C. M., DONNELLY, J. J., & LIU, M. A. (1996) · Immunology · doi:10.1046/j.1365-2567.1996.d01-718.x · Cited by 259
Hohlfeld, R., & Engel, A. G. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90006-x · Cited by 254
Metadata
- Authors
- Barr, E., & Leiden, J. M.
- Venue
- Science
- Published
- 1991-12-06
- Volume
- 254
- Issue
- 5037
- Pages
- 1507-1509
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2034511195
- Cited by
- 281
- References
- 21
- FWCI
- 9.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.